Clinical Trials List
Protocol NumberCAD2017
Completed
2017-08-01 - 2026-08-20
Phase III
Recruiting1
-
Trial Applicant
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- Pei-Hsun Sung Division of Cardiovascular Diseases
- 李芳艷 Division of Cardiovascular Surgery
- 裴松南 Division of Hematology & Oncology
- 馬銘君 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
108 participants
-
Global
0 participants
